Analysts foresee more revenue Pharming

Over the current book year the total revenue will be 186,37 million euros (consensus estimates). This is rather significant more than 2019's revenue of 169,02 million euros.

Historical revenues and results Pharming plus estimates 2020

The analysts expect for 2020 a net profit of 47 million euros. According to most of the analysts the company will have a profit per share for this book year of 6 cent. Based on this the price/earnings-ratio is 15,83.

Analysts don't expect the company to pay a dividend. The average dividend yield of the biotech companies is a low 0,31 percent.

Based on the current number of outstanding shares Pharming's market capitalization is 591,54 million euros. The Pharming stock was the past 12 months quite unstable. Since last October the stock is 14 percent lower. This year the stock price moved between 1 and 2 euro.

Historical stock prices Pharming

Click here for dividend Pharming. At 11.21 the stock trades 2,29 percent lower at 0,95 euros.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.